Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Moderate-to-Severe Asthma, Type 2 Inflammation, and Nocturnal Awakenings: The MORPHEO Randomized Controlled Trial.
Journal: Journal of investigational allergology & clinical immunology
Published: June 29, 2026
Climate change, malaria and neglected tropical diseases: a scoping review.
Journal: Transactions of the Royal Society of Tropical Medicine and Hygiene
Published: March 22, 2024
Effect of Tezepelumab on the Humoral Immune Response to Seasonal Quadrivalent Influenza Vaccination in Patients with Moderate to Severe Asthma: The Phase 3b VECTOR Study.
Journal: Pulmonary therapy
Published: October 04, 2023
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
Journal: The New England journal of medicine
Published: June 05, 2023
Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma.
Journal: Respiratory medicine
Published: April 12, 2023
Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study.
Journal: The European respiratory journal
Published: March 31, 2023
Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results.
Journal: Journal of asthma and allergy
Published: July 31, 2019
Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial.
Journal: Journal of asthma and allergy
Published: December 05, 2018
Inhaled fluticasone furoate/vilanterol does not affect hypothalamic-pituitary-adrenal axis function in adolescent and adult asthma: randomised, double-blind, placebo-controlled study.
Journal: The clinical respiratory journal
Published: January 18, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026